switch to tirzepatide from semaglutide in T2D More Effective Than Upping Dulaglutide Dose TrimRX | How to Switch

Learn more about how our Medical Weight Management Program can support your goals

These L-carnitine tablets support heart and brain function

There are three GLP-1 FDA decisions expected in 2025, all for Novo Nordisks semaglutide: Ozempic for T2DM and peripheral artery disease (PAD) Wegovy SC for heart failure with preserved ejection fraction (HFpEF) and obesity The first oral GLP-1 ( oral formulation of Wegovy 25 mg ) for weight loss and weight loss plus secondary CV risk reduction Given the considerable continued growth expected in the GLP-1 pipeline, Prime Therapeutics talented team of clinical experts actively monitors this emerging landscape

TB-500 is a synthetic peptide fragment corresponding to the active region of Thymosin Beta-4 (TB4) a 43-amino acid G-actin sequestering protein that is one of the most abundant intracellular peptides in mammalian cells

, GLP-1